Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$539,743
+$127,687 QoQ
Shares Held
450
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#3,704
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JNBA Financial Advisors holds $8,063,885 across 15 Drug Manufacturers - General names. LLY ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
9,004 | $2,265,766 | |
| 2 | JNJ |
Johnson & Johnson
|
7,699 | $1,955,315 | |
| 3 | NVS |
Novartis AG
|
6,281 | $984,358 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,494 | $705,979 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,283 | $541,114 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
450 | $539,743 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,281 | $304,291 | |
| 8 | AMGN |
Amgen Inc
|
657 | $237,912 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $539,743 | 450 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $412,056 | 448 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $482,531 | 449 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $338,772 | 444 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $345,331 | 443 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $365,878 | 443 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $385,228 | 499 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $442,084 | 499 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $451,784 | 499 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $489,336 | 629 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $233,168 | 400 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $277,159 | 516 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $257,001 | 548 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $186,820 | 544 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $197,553 | 540 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $174,609 | 540 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $194,213 | 599 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $179,840 | 628 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $173,466 | 628 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $124,767 | 540 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $123,940 | 540 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $100,882 | 540 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $86,108 | 510 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $75,490 | 510 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $83,731 | 510 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $98,491 | 710 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||